MSM (Methylsulfonylmethane) for Joint Pain

Organic sulphur compound providing a bioavailable sulphur source for collagen and keratin synthesis; studied for joint pain, exercise-induced muscle soreness, and allergy symptoms, usually alongside glucosamine.

0reports

-avg rating

-would recommend

On this pageOverview Evidence Community outcomes Related

Why MSM (Methylsulfonylmethane) for Joint Pain?

The connection

Joint discomfort, inflammation, arthritis, and reduced mobility. Affects all ages, worsens with age.

Also known as: MSM, Organic sulphur

Evidence analytics

MSM (Methylsulfonylmethane) × Joint Pain: at a glance

Every published result for this pair, extracted and audited.

These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.

What the evidence shows

Direction of reported outcomes for MSM (Methylsulfonylmethane) in joint pain.

Benefit
No benefit
Unclear

Evidence quality mix

Study designs behind these findings.

Systematic review
Randomised trial

Studies

Reviews & meta-analyses

RCT findings

1,209

Participants (where reported)

Study results, as reported by the publications

Every measured outcome, one row per finding - numbers exactly as reported.

Study	Design	n	Duration	Outcome measured	Reported result	Direction
PMID 18417375 2008	Systematic review	681	-	pain in knee osteoarthritis, DMSO vs comparator	reported qualitatively	Unclear
PMID 18417375 2008	Systematic review	168	-	pain in knee osteoarthritis, MSM vs placebo	reported qualitatively	Benefit
PMID 29214616 2017	Randomised trial	180	8 weeks	Knee Osteoarthritis Outcome Score (KOOS)	reported qualitatively	No benefit
PMID 29214616 2017	Randomised trial	180	8 weeks	Profile of Moods States (POMS)	reported qualitatively	No benefit

← Zoom out: all evidence for MSM (Methylsulfonylmethane)Zoom out: compare compounds for Joint Pain →

Peer-reviewed research

MSM (Methylsulfonylmethane) × Joint Pain: the evidence base

Hand-selected PubMed studies, linked to the originals.

6studies referenced

6journals

2025–2026publication range

Ordered by strength of evidence, then result direction.

01Efficacy and Safety of Anti-nerve Growth Factor Monoclonal Antibodies in Managing Chronic Musculoskeletal Pain: A Systematic Review with Network Meta-analysisAbouelella A, et al. · Drugs · 2026PMID 41880116 ↗02Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trialsSimental-Mendía M, et al. · Clinical and experimental rheumatology · 2025PMID 39212129 ↗03A meta-analysis and systematic review of the clinical efficacy and safety of platelet-rich plasma combined with hyaluronic acid (PRP + HA) versus PRP monotherapy for knee osteoarthritis (KOA)Du D, et al. · Journal of orthopaedic surgery and research · 2025PMID 39819683 ↗04Efficacy of dietary supplements for treating knee osteoarthritis: a systematic review and network meta-analysis

Community outcomes

No community reports yet.

Be the first to share what you noticed with MSM (Methylsulfonylmethane) for joint pain. How we calculate this.

Share your experience

Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.